Senderra Shines at NORM 2024: People's Choice Award Win Highlights Continued Excellence

Senderra Shines at NORM 2024: People's Choice Award Win Highlights Continued Excellence

Last week, Senderra attended the National Organization of Rheumatology Management (NORM) annual conference, a key event designed to support leaders in rheumatology practice management. The conference offers valuable insights through educational sessions, networking opportunities, and expert panels, all aimed at enhancing care delivery for rheumatology patients. This year, Senderra was awarded 1st place in the People's Choice Award, following last year's Best in Show honor. These recognitions underscore Senderra's commitment to innovation and excellence in specialty pharmacy services.

For more details, visit NORM and NORM Conference.

norm 1st place cropped
norm 2024
Image (55)
norm 2024 2
Senderra Specialty Pharmacy introduces a data-driven, patient-focused digital solution, Pharma Navigator

Senderra Specialty Pharmacy introduces a data-driven, patient-focused digital solution, Pharma Navigator

Pharma Navigator revolutionizes pharmaceutical management for manufacturers and providers alike by empowering patient pull-through, delivering...

Read More
Senderra Recognized on the 2025 Inc. 5000 List for Second Consecutive Year

Senderra Recognized on the 2025 Inc. 5000 List for Second Consecutive Year

Senderra Specialty Pharmacy Earns Spot on the 2025 Inc. 5000 List of Fastest-Growing Private Companies for Second Consecutive Year

Read More
Elevating Patient Care: Senderra Specialty Pharmacy Adds Lilly's EBGLYSS™ (lebrikizumab-lbkz) to SenderraCare+

Elevating Patient Care: Senderra Specialty Pharmacy Adds Lilly's EBGLYSS™ (lebrikizumab-lbkz) to SenderraCare+

SenderraCare+ redefines specialty therapy by consolidating enrollment, adherence support, and medication management into one intuitive, in real-time...

Read More